Trial Profile
Clinical Trials Insight: 700013087
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 May 2006
Price :
$35
*
At a glance
- Drugs Carbendazim (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors AmpliMed
- 24 May 2006 New trial record.